U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials
The U.S. Senate last night passed the “Improving Access to Clinical Trials Act” (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.
Read more on News-Medical-Net
- 2012 U.S. Healthcare PPACA: Supreme Court Decision and What Really Matters to Doctors and Hospitals
- Health Partners America, LLC, Announces Launch of Customizable Private Exchange Technology to Enable Insurance Agents to Participate in Growing Defined Contribution Health Insurance Market
- 2012: Patient’s (Doctor’s) Bill Of Rights – PPACA & ERISA Outlaws Anti-Assignment by Insurance Companies
- Superintendents weigh in on Ohio Senate Bill 5
- U.S. Patent Awarded to Brain State Technologies